Champlain Investment Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Buy
+269,217
New +$17.9M 0.47% 104
2025
Q4
Sell
-1,086,120
Closed -$73.1M 134
2025
Q3
$73.1M Sell
1,086,120
-704,980
-39% -$55.8M 0.55% 80
2025
Q2
$156M Sell
1,791,100
-71,320
-4% -$5.59M 1.09% 29
2025
Q1
$127M Sell
1,862,420
-153,293
-8% -$12.5M 0.92% 38
2024
Q4
$157M Sell
2,015,713
-197,570
-9% -$14.6M 0.99% 32
2024
Q3
$148M Buy
2,213,283
+163,210
+8% +$13.4M 0.9% 41
2024
Q2
$232M Sell
2,050,073
-6,080
-0.3% -$769K 1.43% 15
2024
Q1
$285M Sell
2,056,153
-53,830
-3% -$6.77M 1.63% 8
2023
Q4
$262M Sell
2,109,983
-47,735
-2% -$4.88M 1.55% 11
2023
Q3
$201M Buy
2,157,718
+264,220
+14% +$29.8M 1.31% 16
2023
Q2
$243M Buy
1,893,498
+6,110
+0.3% +$739K 1.5% 15
2023
Q1
$219M Buy
1,887,388
+115,429
+7% +$12.9M 1.38% 15
2022
Q4
$201M Sell
1,771,959
-13,705
-0.8% -$1.5M 1.29% 17
2022
Q3
$144M Buy
1,785,664
+275,086
+18% +$23.3M 0.98% 34
2022
Q2
$113M Buy
1,510,578
+934,258
+162% +$85.3M 0.73% 60
2022
Q1
$73.7M Buy
+576,320
New +$63M 0.38% 98

Other funds holding DXCM

Champlain Investment Partners's DXCM Position: Q2 2026 in Review

Champlain Investment Partners opened a new position in DexCom (DXCM) in Q2 2026: 269,217 shares worth $18.1M. The stake represents 0.47% of the portfolio and ranks #104 among its holdings. This is a return to the name: Champlain Investment Partners previously reported a position in DXCM as recently as Q3 2025.

Champlain Investment Partners first reported a position in DXCM in Q1 2022 and has held it in 16 quarters since. The position peaked at $285M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Champlain Investment Partners held 269,217 shares of DexCom worth $18.1M as of Q2 2026.
  • DexCom was a new Champlain Investment Partners position in Q2 2026.
  • DexCom made up 0.47% of Champlain Investment Partners's portfolio in Q2 2026, its #104 holding.
  • Champlain Investment Partners first reported a position in DexCom in Q1 2022 and has held it in 16 quarters since.
  • Champlain Investment Partners's DexCom position peaked at $285M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.